comparemela.com

Latest Breaking News On - Avidity analyzer - Page 1 : comparemela.com

LUMICKS: Cancer Cell Paper Identifies Avidity Enhancement As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia

Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To "Avidity Enhancement" AMSTERDAM, May 24, 2022 /PRNewswire/ LUMICKS, a leading

United statesNoord hollandPaul wheelerMarcelav mausAndrea candelliMaus labProfessor of medicine at harvard medical schoolCancer cellChimeric antigen receptorAcute myeloid leukemiaAssociate professorHarvard medical schoolMassachusetts generalAvidity analyzerMovi cell avidity analyzerChief scientific officer

LUMICKS Appoints Andre Nel as Chief Financial Officer

Life Sciences Finance Veteran To Help Company Scale Globally AMSTERDAM, May 9, 2022 /PRNewswire/ LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule

South africaUnited kingdomNoord hollandRussian federationKostenloser wertpapierhandelJoshua youngJandre nelOlivier heyningKassandra barbetseaUniversity of johannesburgChief financialChief financial officerDante labsVice presidentFinance director russian federationGlobal transformation

New Customer Installation of LUMICKS z-Movi Cell Avidity Analyzer Confirms Value of Cell Avidity Measurement in Leading Labs Studying Biomarkers of Immune Oncology

New Customer Represents Leading-Edge Scientific Research AMSTERDAM, April 21, 2022 /PRNewswire/ LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule

Noord hollandKassandra barbetseaDirk buschElvira dippolitoTechnical university of munichSchool of medicineBusch labEdge scientific researchNew customer represents leading edge scientificAvidity analyzerMedical microbiologyTechnical universityElvirad ippolitoGerrit sittersGeneral managerAvidity business

LUMICKS Strengthens its Innovative C-Trap Solution with Launch of New Lakeview Analysis Software Platform

Lakeview software enables easier data analysis, solidifying the end-to-end C-Trap solution for dynamic single-molecule analysis, and democratizing use by researchers AMSTERDAM, April 5

United statesNoord hollandJos maasKassandra barbetseaExperimental biologyGeneral managerLakeview platformDynamic single moleculeCell avidityLabel free microscopyAvidity analyzer

LUMICKS: Frontiers in Immunology Paper Discloses Promising New Insights into CAR T Cell Efficacy for Cancer Therapies

AMSTERDAM, March 17, 2022 /PRNewswire/ LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that

City ofUnited kingdomNoord hollandJohn maherAndrea candelliKassandra barbetseaLeucid bioKings college londonSchool of cancer pharmaceutical sciencesSenior lecturer at kings college londonKings collegeChimeric antigen receptorSenior lecturerPharmaceutical sciencesChief scientific officerMovi cell avidity analyzer

vimarsana © 2020. All Rights Reserved.